Cytomegalovirus primary infection in a patient with multiple sclerosis treated with alemtuzumab

We report one patient with MS who develops cytomegalovirus (CMV) primary infection after a third cycle of alemtuzumab, with spontaneous recovery associated with rapid lymphocyte reconstitution.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research